{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:11:07Z","timestamp":1783941067021,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Incubation Project of Mianyang Central Hospital","award":["2023FH002"],"award-info":[{"award-number":["2023FH002"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202911"],"award-info":[{"award-number":["82202911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300786"],"award-info":[{"award-number":["82300786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Clear cell renal cell carcinoma (ccRCC) is known for abnormal lipid metabolism and widespread activation of HIF-2\u03b1. Recently, the importance of autophagy in ccRCC has been focused, and it has potential connections with HIF-2\u03b1 and lipid metabolism. However, the specific regulatory mechanism between HIF-2\u03b1, autophagy, and lipid metabolism in ccRCC is still unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, Bioinformatics Analysis and Sequencing of the whole transcriptome were used to screen our target. The expression of TBC1D5 in renal clear cell carcinoma was confirmed by database analysis, immunohistochemistry, PCR and Western blot. The effects of TBC1D5 on tumor cell growth, migration, invasion and lipid metabolism were examined by CCK8, Transwell and oil red staining, and the mechanism of TBC1D5 on autophagy was investigated by Western blot, fluorescence microscopy and electron microscopy. Chloroquine and rapamycin were used to verified the key role of autophagy in effects of TBC1D5 on tumor cell. The regulatory mechanism of TBC1D5 in renal clear cell carcinoma (RCC) was investigated by shhif-2\u03b1, shTBC1D5, mimic, inhibitor, ChIP and Luciferase experiments. The animal model of ccRCC was used to evaluate the biological function of TBC1D5 in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, TBC1D5 was found to be an important bridge between autophagy and HIF-2\u03b1. Specifically, TBC1D5 is significantly underexpressed in ccRCC, serving as a tumor suppressor which inhibits tumor progression and lipid accumulation, and is negatively regulated by HIF-2\u03b1. Further research has found that TBC1D5 regulates the autophagy pathway to reverse the biological function of HIF-2\u03b1 in ccRCC. Mechanism studies have shown that HIF-2\u03b1 regulates TBC1D5 through hsa-miR-7-5p in ccRCC, thereby affecting tumor progression and lipid metabolism through autophagy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our research reveals a completely new pathway, HIF-2\u03b1\/hsa-miR-7-5p\/TBC1D5 pathway affects ccRCC progression and lipid metabolism by regulating autophagy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12967-024-05015-y","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T07:02:37Z","timestamp":1709103757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["TBC1D5 reverses the capability of HIF-2\u03b1 in tumor progression and lipid metabolism in clear cell renal cell carcinoma by regulating the autophagy"],"prefix":"10.1186","volume":"22","author":[{"given":"Yu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-4818","authenticated-orcid":false,"given":"Xiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"issue":"1","key":"5015_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"5015_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Gr\u00fcnwald V, Gillessen S, Horwich A. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2019;30(5):706\u201320.","journal-title":"Ann Oncol"},{"issue":"3","key":"5015_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","volume":"34","author":"K Gupta","year":"2008","unstructured":"Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34(3):193\u2013205.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"5015_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","volume":"67","author":"B Shuch","year":"2015","unstructured":"Shuch B, Amin A, Armstrong AJ, Eble JN, Ficarra V, Lopez-Beltran A, Martignoni G, Rini BI, Kutikov A. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol. 2015;67(1):85\u201397.","journal-title":"Eur Urol"},{"issue":"7","key":"5015_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrneph.2017.59","volume":"13","author":"HI Wettersten","year":"2017","unstructured":"Wettersten HI, Aboud OA, Lara PN Jr, Weiss RH. Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol. 2017;13(7):410\u20139.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"5015_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/path.2689","volume":"221","author":"MM Baldewijns","year":"2010","unstructured":"Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruine AP. VHL and HIF signalling in renal cell carcinogenesis. J Pathol. 2010;221(2):125\u201338.","journal-title":"J Pathol"},{"issue":"7627","key":"5015_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature19796","volume":"539","author":"W Chen","year":"2016","unstructured":"Chen W, Hill H, Christie A, Kim MS, Holloman E, Pavia-Jimenez A, Homayoun F, Ma Y, Patel N, Yell P, Hao G, Yousuf Q, Joyce A, Pedrosa I, Geiger H, Zhang H, Chang J, Gardner KH, Bruick RK, Reeves C, Hwang TH, Courtney K, Frenkel E, Sun X, Zojwalla N, Wong T, Rizzi JP, Wallace EM, Josey JA, Xie Y, Xie XJ, Kapur P, McKay RM, Brugarolas J. Targeting renal cell carcinoma with a HIF-2 antagonist. Nature. 2016;539(7627):112\u20137.","journal-title":"Nature"},{"issue":"48","key":"5015_CR8","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/sj.onc.1203938","volume":"19","author":"M Krieg","year":"2000","unstructured":"Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene. 2000;19(48):5435\u201343.","journal-title":"Oncogene"},{"issue":"7777","key":"5015_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/d41586-019-02963-0","volume":"574","author":"H Ledford","year":"2019","unstructured":"Ledford H, Callaway E. Biologists who decoded how cells sense oxygen win medicine Nobel. Nature. 2019;574(7777):161\u20132.","journal-title":"Nature"},{"issue":"4","key":"5015_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.eururo.2015.08.007","volume":"69","author":"J Schodel","year":"2016","unstructured":"Schodel J, Grampp S, Maher ER, Moch H, Ratcliffe PJ, Russo P, Mole DR. Hypoxia, hypoxia-inducible transcription factors, and renal cancer. Eur Urol. 2016;69(4):646\u201357.","journal-title":"Eur Urol"},{"issue":"6","key":"5015_CR11","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1158\/2159-8290.CD-14-1507","volume":"5","author":"B Qiu","year":"2015","unstructured":"Qiu B, Ackerman D, Sanchez DJ, Li B, Ochocki JD, Grazioli A, Bobrovnikova-Marjon E, Diehl JA, Keith B, Simon MC. HIF2alpha-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma. Cancer Discov. 2015;5(6):652\u201367.","journal-title":"Cancer Discov"},{"issue":"7","key":"5015_CR12","doi-asserted-by":"publisher","first-page":"292.e217","DOI":"10.1016\/j.urolonc.2016.01.001","volume":"34","author":"SR Williamson","year":"2016","unstructured":"Williamson SR, Cheng L. Clear cell renal cell tumors: not all that is \u201cclear\u201d is cancer. Urol Oncol. 2016;34(7):292.e217-222.","journal-title":"Urol Oncol"},{"issue":"1","key":"5015_CR13","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41467-017-01965-8","volume":"8","author":"W Du","year":"2017","unstructured":"Du W, Zhang L, Brett-Morris A, Aguila B, Kerner J, Hoppel CL, Puchowicz M, Serra D, Herrero L, Rini BI, Campbell S, Welford SM. HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism. Nat Commun. 2017;8(1):1769.","journal-title":"Nat Commun"},{"issue":"3","key":"5015_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/ars.2013.5371","volume":"20","author":"KR Parzych","year":"2014","unstructured":"Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014;20(3):460\u201373.","journal-title":"Antioxid Redox Signal"},{"issue":"Suppl 2","key":"5015_CR15","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/sj.cdd.4401765","volume":"12","author":"T Yorimitsu","year":"2005","unstructured":"Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005;12(Suppl 2):1542\u201352.","journal-title":"Cell Death Differ"},{"key":"5015_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-981-15-0602-4_16","volume":"1206","author":"J Yang","year":"2019","unstructured":"Yang J, Zhou R, Ma Z. Autophagy and energy metabolism. Adv Exp Med Biol. 2019;1206:329\u201357.","journal-title":"Adv Exp Med Biol"},{"issue":"7242","key":"5015_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131\u20135.","journal-title":"Nature"},{"key":"5015_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","volume":"43","author":"C He","year":"2009","unstructured":"He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43:67\u201393.","journal-title":"Annu Rev Genet"},{"issue":"4","key":"5015_CR19","first-page":"269","volume":"1861","author":"C Ward","year":"2016","unstructured":"Ward C, Martinez-Lopez N, Otten EG, Carroll B, Maetzel D, Singh R, Sarkar S, Korolchuk VI. Autophagy, lipophagy and lysosomal lipid storage disorders. Biochem Biophys Acta. 2016;1861(4):269\u201384.","journal-title":"Biochem Biophys Acta"},{"issue":"3","key":"5015_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.bbrc.2018.02.097","volume":"504","author":"M Maan","year":"2018","unstructured":"Maan M, Peters JM, Dutta M, Patterson AD. Lipid metabolism and lipophagy in cancer. Biochem Biophys Res Commun. 2018;504(3):582\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"5015_CR21","doi-asserted-by":"publisher","DOI":"10.4161\/23723556.2014.985913","volume":"2","author":"L Lin","year":"2015","unstructured":"Lin L, Baehrecke EH. Autophagy, cell death, and cancer. Mol Cell Oncol. 2015;2(3): e985913.","journal-title":"Mol Cell Oncol"},{"issue":"9","key":"5015_CR22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00432-015-1923-4","volume":"141","author":"M Nishikawa","year":"2015","unstructured":"Nishikawa M, Miyake H, Liu B, Fujisawa M. Expression pattern of autophagy-related markers in non-metastatic clear cell renal cell carcinoma: association with disease recurrence following radical nephrectomy. J Cancer Res Clin Oncol. 2015;141(9):1585\u201391.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"5015_CR23","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.21873\/anticanres.12916","volume":"38","author":"M Santoni","year":"2018","unstructured":"Santoni M, Piva F, De Giorgi U, Mosca A, Basso U, Santini D, Buti S, Lolli C, Terrone C, Maruzzo M, Iuliani M, Bersanelli M, Conti A, Mazzucchelli R, Montironi R, Burattini L, Berardi R. Autophagic gene polymorphisms in liquid biopsies and outcome of patients with metastatic clear cell renal cell carcinoma. Anticancer Res. 2018;38(10):5773\u201382.","journal-title":"Anticancer Res"},{"issue":"12","key":"5015_CR24","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/jjco\/hyt160","volume":"43","author":"Q Deng","year":"2013","unstructured":"Deng Q, Wang Z, Wang L, Zhang L, Xiang X, Wang Z, Chong T. Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma. Jpn J Clin Oncol. 2013;43(12):1261\u20138.","journal-title":"Jpn J Clin Oncol"},{"issue":"19","key":"5015_CR25","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1038\/onc.2014.199","volume":"34","author":"XD Liu","year":"2015","unstructured":"Liu XD, Yao J, Tripathi DN, Ding Z, Xu Y, Sun M, Zhang J, Bai S, German P, Hoang A, Zhou L, Jonasch D, Zhang X, Conti CJ, Efstathiou E, Tannir NM, Eissa NT, Mills GB, Walker CL, Jonasch E. Autophagy mediates HIF2alpha degradation and suppresses renal tumorigenesis. Oncogene. 2015;34(19):2450\u201360.","journal-title":"Oncogene"},{"issue":"9","key":"5015_CR26","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1083\/jcb.201812110","volume":"218","author":"A Kvainickas","year":"2019","unstructured":"Kvainickas A, Nagele H, Qi W, Dokladal L, Jimenez-Orgaz A, Stehl L, Gangurde D, Zhao Q, Hu Z, Dengjel J, De Virgilio C, Baumeister R, Steinberg F. Retromer and TBC1D5 maintain late endosomal RAB7 domains to enable amino acid-induced mTORC1 signaling. J Cell Biol. 2019;218(9):3019\u201338.","journal-title":"J Cell Biol"},{"issue":"9","key":"5015_CR27","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1128\/MCB.06717-11","volume":"32","author":"D Popovic","year":"2012","unstructured":"Popovic D, Akutsu M, Novak I, Harper JW, Behrends C, Dikic I. Rab GTPase-activating proteins in autophagy: regulation of endocytic and autophagy pathways by direct binding to human ATG8 modifiers. Mol Cell Biol. 2012;32(9):1733\u201344.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"5015_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.15252\/embj.201797128","volume":"37","author":"A Jimenez-Orgaz","year":"2018","unstructured":"Jimenez-Orgaz A, Kvainickas A, N\u00e4gele H, Denner J, Eimer S, Dengjel J, Steinberg F. Control of RAB7 activity and localization through the retromer-TBC1D5 complex enables RAB7-dependent mitophagy. EMBO J. 2018;37(2):235\u201354.","journal-title":"EMBO J"},{"issue":"18","key":"5015_CR29","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/jnci\/djj362","volume":"98","author":"JM Hollingsworth","year":"2006","unstructured":"Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98(18):1331\u20134.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"5015_CR30","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","volume":"373","author":"RJ Motzer","year":"2015","unstructured":"Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Procopio G, Plimack ER, Castellano D, Choueiri TK, Gurney H, Donskov F, Bono P, Wagstaff J, Gauler TC, Ueda T, Tomita Y, Schutz FA, Kollmannsberger C, Larkin J, Ravaud A, Simon JS, Xu LA, Waxman IM, Sharma P. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med. 2015;373(19):1803\u201313.","journal-title":"N Engl J Med"},{"issue":"9807","key":"5015_CR31","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/S0140-6736(11)61613-9","volume":"378","author":"BI Rini","year":"2011","unstructured":"Rini BI, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson TE, Michaelson MD, Gorbunova VA, Gore ME, Rusakov IG, Negrier S, Ou YC, Castellano D, Lim HY, Uemura H, Tarazi J, Cella D, Chen C, Rosbrook B, Kim S, Motzer RJ. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Lancet. 2011;378(9807):1931\u20139.","journal-title":"Lancet"},{"issue":"18","key":"5015_CR32","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1002\/cncr.33033","volume":"126","author":"RJ Motzer","year":"2020","unstructured":"Motzer RJ, Escudier B, George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Plimack ER, Procopio G, McDermott DF, Castellano D, Choueiri TK, Donskov F, Gurney H, Oudard S, Richardet M, Peltola K, Alva AS, Carducci M, Wagstaff J, Chevreau C, Fukasawa S, Tomita Y, Gauler TC, Kollmannsberger CK, Schutz FA, Larkin J, Cella D, McHenry MB, Saggi SS, Tannir NM. Nivolumab versus everolimus in patients with advanced renal cell carcinoma: updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial. Cancer. 2020;126(18):4156\u201367.","journal-title":"Cancer"},{"issue":"3","key":"5015_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/BSR20100112","volume":"31","author":"M Fukuda","year":"2011","unstructured":"Fukuda M. TBC proteins: GAPs for mammalian small GTPase Rab? Biosci Rep. 2011;31(3):159\u201368.","journal-title":"Biosci Rep"},{"issue":"2","key":"5015_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrm3267","volume":"13","author":"MA Frasa","year":"2012","unstructured":"Frasa MA, Koessmeier KT, Ahmadian MR, Braga VM. Illuminating the functional and structural repertoire of human TBC\/RABGAPs. Nat Rev Mol Cell Biol. 2012;13(2):67\u201373.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"5015_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3904\/kjim.2015.30.1.62","volume":"30","author":"ST Uh","year":"2015","unstructured":"Uh ST, Koo SM, Jang AS, Park SW, Choi JS, Kim YH, Park CS. Proteomic differences with and without ozone-exposure in a smoking-induced emphysema lung model. Korean J Intern Med. 2015;30(1):62\u201372.","journal-title":"Korean J Intern Med"},{"issue":"4","key":"5015_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/embr.201337995","volume":"15","author":"D Popovic","year":"2014","unstructured":"Popovic D, Dikic I. TBC1D5 and the AP2 complex regulate ATG9 trafficking and initiation of autophagy. EMBO Rep. 2014;15(4):392\u2013401.","journal-title":"EMBO Rep"},{"issue":"10","key":"5015_CR37","doi-asserted-by":"publisher","first-page":"1801862","DOI":"10.1002\/advs.201801862","volume":"6","author":"Z Xiong","year":"2019","unstructured":"Xiong Z, Xiao W, Bao L, Xiong W, Xiao H, Qu Y, Yuan C, Ruan H, Cao Q, Wang K, Song Z, Wang C, Hu W, Ru Z, Tong J, Cheng G, Xu T, Meng X, Shi J, Chen Z, Yang H, Chen K, Zhang X. Tumor cell \u201cslimming\u201d regulates tumor progression through PLCL1\/UCP1-mediated lipid browning. Adv Sci. 2019;6(10):1801862.","journal-title":"Adv Sci"},{"issue":"4","key":"5015_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12607","volume":"67","author":"W Xiao","year":"2019","unstructured":"Xiao W, Xiong Z, Xiong W, Yuan C, Xiao H, Ruan H, Song Z, Wang C, Bao L, Cao Q, Wang K, Cheng G, Xu T, Tong J, Zhou L, Hu W, Ru Z, Liu D, Yang H, Zhang X, Chen K. Melatonin\/PGC1A\/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning. J Pineal Res. 2019;67(4): e12607.","journal-title":"J Pineal Res"}],"updated-by":[{"DOI":"10.1186\/s12967-024-05189-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000}}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05015-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T08:11:20Z","timestamp":1716797480000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05015-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5015"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05015-y","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12967-024-05189-5","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"24 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12967-024-05189-5","URL":"https:\/\/doi.org\/10.1186\/s12967-024-05189-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}